Search Results - "OKUNO, S"

Refine Results
  1. 1

    An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas by Agulnik, M., Yarber, J.L., Okuno, S.H., von Mehren, M., Jovanovic, B.D., Brockstein, B.E., Evens, A.M., Benjamin, R.S.

    Published in Annals of oncology (01-01-2013)
    “…To determine efficacy and safety of bevacizumab, a recombinant humanized antibody against vascular endothelial growth factor (VEGF), in the treatment of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Direct Measurement of the Cosmic-Ray Carbon and Oxygen Spectra from 10 GeV/n to 2.2 TeV/n with the Calorimetric Electron Telescope on the International Space Station by Adriani, O., Akaike, Y., Asano, K., Asaoka, Y., Bagliesi, M. G., Berti, E., Bigongiari, G., Binns, W. R., Bongi, M., Brogi, P., Bruno, A., Buckley, J. H., Cannady, N., Castellini, G., Checchia, C., Cherry, M. L., Collazuol, G., Ebisawa, K., Fuke, H., Gonzi, S., Guzik, T. G., Hams, T., Hibino, K., Ichimura, M., Ioka, K., Ishizaki, W., Israel, M. H., Kasahara, K., Kataoka, J., Kataoka, R., Katayose, Y., Kato, C., Kawanaka, N., Kawakubo, Y., Kobayashi, K., Kohri, K., Krawczynski, H. S., Krizmanic, J. F., Link, J., Maestro, P., Marrocchesi, P. S., Messineo, A. M., Mitchell, J. W., Miyake, S., Moiseev, A. A., Mori, M., Mori, N., Motz, H. M., Munakata, K., Nakahira, S., Nishimura, J., Nolfo, G. A. De, Okuno, S., Ormes, J. F., Ospina, N., Ozawa, S., Pacini, L., Palma, F., Papini, P., Rauch, B. F., Ricciarini, S. B., Sakai, K., Sakamoto, T., Sasaki, M., Shimizu, Y., Shiomi, A., Sparvoli, R., Spillantini, P., Stolzi, F., Sugita, S., Suh, J. E., Sulaj, A., Takita, M., Tamura, T., Terasawa, T., Torii, S., Tsunesada, Y., Uchihori, Y., Vannuccini, E., Wefel, J. P., Yamaoka, K., Yanagita, S., Yoshida, A., Yoshida, K.

    Published in Physical review letters (18-12-2020)
    “…In this paper, we present the measurement of the energy spectra of carbon and oxygen in cosmic rays based on observations with the Calorimetric Electron…”
    Get full text
    Journal Article
  5. 5

    Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors by Dickson, M.A., Okuno, S.H., Keohan, M.L., Maki, R.G., D'Adamo, D.R., Akhurst, T.J., Antonescu, C.R., Schwartz, G.K.

    Published in Annals of oncology (01-01-2013)
    “…HSP90 inhibition leads to proteosomal degradation of activated KIT and has in vitro activity against gastrointestinal stromal tumors (GIST). BIIB021 is an oral…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis by Nagata, Y., Inaba, M., Imanishi, Y., Okazaki, H., Yamada, S., Mori, K., Shoji, S., Koyama, H., Okuno, S.

    Published in Osteoporosis international (01-03-2015)
    “…Summary Serum undercarboxylated osteocalcin (ucOC)/intact osteocalcin (iOC) ratio increased >1.0 in the patients undergoing hemodialysis, particularly in those…”
    Get full text
    Journal Article
  10. 10

    Geriatric Nutritional Risk Index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients by Kobayashi, Ikue, Ishimura, Eiji, Kato, Yoko, Okuno, Senji, Yamamoto, Tadashi, Yamakawa, Tomoyuki, Mori, Katsuhito, Inaba, Masaaki, Nishizawa, Yoshiki

    Published in Nephrology, dialysis, transplantation (01-10-2010)
    “…Background. Malnutrition is a common complication in haemodialysis patients. Recently, the Geriatric Nutritional Risk Index (GNRI) has been reported as a…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Deposition of silicon-doped diamond-like carbon films by plasma-enhanced chemical vapor deposition using an intermittent supply of organosilane by Nakazawa, H., Kamata, R., Okuno, S.

    Published in Diamond and related materials (01-01-2015)
    “…We have deposited Si-doped DLC (Si-DLC) multilayer films by plasma-enhanced chemical vapor deposition (PECVD) using an intermittent supply of monomethylsilane…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas by GALANIS, E, OKUNO, S. H, RANDLEV, B, WANG, Q, FREEMAN, S, RUBIN, J, NASCIMENTO, A. G, LEWIS, B. D, LEE, R. A, OLIVEIRA, A. M, SLOAN, J. A, ATHERTON, P, EDMONSON, J. H, ERLICHMAN, C

    Published in Gene therapy (01-03-2005)
    “…ONYX-015 is a provisionally replication competent adenovirus with oncolytic activity in cells with malfunctioning p53. Sarcomas represent a rational target for…”
    Get full text
    Journal Article
  17. 17

    Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients by Okuno, S., Ishimura, E., Tsuboniwa, N., Norimine, K., Yamakawa, K., Yamakawa, T., Shoji, S., Mori, K., Nishizawa, Y., Inaba, M.

    Published in Osteoporosis international (01-02-2013)
    “…Summary Increased levels of serum undercarboxylated osteocalcin, which were associated with bone metabolism markers, correlated inversely with indices of…”
    Get full text
    Journal Article
  18. 18

    A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas by Agulnik, M., Costa, R.L.B., Milhem, M., Rademaker, A.W., Prunder, B.C., Daniels, D., Rhodes, B.T., Humphreys, C., Abbinanti, S., Nye, L., Cehic, R., Polish, A., Vintilescu, C., McFarland, T., Skubitz, K., Robinson, S., Okuno, S., Van Tine, B.A.

    Published in Annals of oncology (01-01-2017)
    “…Soft tissue sarcomas (STSs) overexpress vascular endothelial growth factors (VEGF) and VEGF-receptors (VEGFR) activation have been associated with tumor…”
    Get full text
    Journal Article
  19. 19

    Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients by INABA, M, OKUNO, S, IMANISHI, Y, YAMADA, S, SHIOI, A, YAMAKAWA, T, ISHIMURA, E, NISHIZAWA, Y

    Published in Osteoporosis international (01-10-2006)
    “…Fibroblast growth factor (FGF) 23 is a recently identified circulating factor that regulates phosphate (Pi) metabolism. Since the derangement of Pi control is…”
    Get full text
    Journal Article
  20. 20

    Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients by Ishimura, E, Okuno, S, Kitatani, K, Tsuchida, T, Yamakawa, T, Shioi, A, Inaba, M, Nishizawa, Y

    Published in Clinical nephrology (01-10-2007)
    “…Vascular calcification, which significantly increases cardiovascular and other causes of mortality, is highly prevalent in hemodialysis patients. The aim of…”
    Get more information
    Journal Article